Home > Physicians
Physician Information
Prostate Cancer Treatment
with Ablatherm® HIFU
Ablatherm® HIFU is a treatment option
for localized prostate cancer that is setting a new standard
of care for prostate cancer patients. As will be discussed later,
complications are minimal and cure rates compare favorably with
radical surgery.
A Less Invasive Option is Available Today
Many patients cannot tolerate the side effects associated with
radiation. Additionally, not all prostate cancer patients can
or want to undergo surgery. For these patients Ablatherm® HIFU
offers an excellent alternative.
Proven Results
After ten years of development, and thousands of patients treated,
Ablatherm® HIFU has emerged as the most promising amongst
non-invasive treatment options for localized prostate cancer
available today.
Availability
The interest of the urological community for this new treatment
is now rapidly increasing. Urologists throughout many countries
now widely accept Ablatherm® HIFU as the most effective non-invasive
alternative treatment for localized prostate cancer. It also
has fewer side effects than any other treatment.
Why Ablatherm® HIFU?
Treatment with the Ablatherm® HIFU is usually performed
as an outpatient procedure and patient recovery is almost immediate.
Also, there is the possibility of repeating the treatment if
necessary as indicated by either a rising PSA or by a positive
prostate biopsy. Re-treatment rates in most series are approximately
10%. This section of our website is designed to introduce you
to the Ablatherm® HIFU technology. Should you have any questions
please contact us.
Benefits of Ablatherm® HIFU
- Non-Invasive: no port, no seeds, no radiation
- Effective: precise and definitive necrosis of the targeted
area
- Early Feedback: nadir PSA after only 3 months
- Quality of Life: minimal side effects
- Repeatable: if needed at any time during follow up
- Adaptable: to the physician and the patient's therapeutic
goals
- No Therapeutic impasse: alternative options still open post-Ablatherm® HIFU
|
